Skip to main content
Clinical Trials/CTRI/2022/11/047262
CTRI/2022/11/047262Not yet recruitingPhase 3

Role of Taurine Supplementation in Neurological Recovery of Acute Spinal Cord Injury (ASCI) Subjects: A Non Randomized Control Clinical Trial

King georges medical university,Department of Orhopaedic Surgery0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for controls
  • Age and sex matched healthy controls were amongst the attendants of the ASCI subjects, having no known pathology and gave their consent to participate in the study.
  • Inclusion criterion for ASCI subjects
  • 1. Age 18 - 65 years of either gender,
  • 2. ASCI <3 weeks of injury
  • 3. Complete motor injury (AIS-A, B)

Exclusion Criteria

  • Exclusion criterion for ASCI subjects
  • 1.Other associated injuries such as major thoracoabdominal injuries & head injuries needing intervention.
  • 2.Neuro-psychiatric patients and patients on steroid or other immunosuppressant therapy or other comorbid conditions making subjects unfit for surgery.
  • 3.Subjects with non-vegetarian diet.
  • 4.Subjects who do not give consent for participating in the study.

Investigators

Sponsor
King georges medical university,Department of Orhopaedic Surgery

Similar Trials

A clinical trial to study the effect of a... | Clinical Trial